Press releases

Month Year

Email alerts

Jul 31, 2018

Medtronic Receives FDA Approval for Implantable System for Remodulin® to Treat Patients with Pulmonary Arterial Hypertension

GLOBE NEWSWIRE via COMTEX) --Medtronic SynchroMed(TM) II Pump, Proprietary Catheter Deliver United Therapeutics' Remodulin® (treprostinil) Injection DUBLIN - July 31, 2018 - Medtronic plc...
Jul 25, 2018

Medtronic to Provide Public Comment During CMS Committee Meeting on Volume Requirements for Transcatheter Aortic Valve Replacement (TAVR)

Company to Emphasize the Importance of Evidenced-Based Quality Outcomes and Appropriate Patient Access

DUBLIN and BALTIMORE - July 25, 2018 - Medtronic plc (NYSE:MDT), a global leader in heart valve therapies, will deliver public comment during the Centers for Medicare & Medicaid Services (CMS)...
Jul 19, 2018

Medtronic Clinical Trial to Evaluate ECG Belt for Optimizing Heart Failure Therapy

(GLOBE NEWSWIRE via COMTEX) --DUBLIN - July 19, 2018 - Medtronic plc (NYSE: MDT) today announced first enrollments in a new clinical trial evaluating the ECG (electrocardiography) Belt Research...
Jul 12, 2018

Medtronic Wins Expanded Indication for SelectSecure(TM) MRI SureScan(TM) Pacing Lead for His Bundle Site Stimulation

GLOBE NEWSWIRE via COMTEX) --DUBLIN - July 12, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure(TM) MRI...
Jul 11, 2018

Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure

(GLOBE NEWSWIRE via COMTEX) --HeartWare(TM) HVAD(TM) System Only LVAD Approved for Implant via Thoracotomy or Median Sternotomy

DUBLIN - July 11, 2018 - Medtronic plc (NYSE: MDT) has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD(TM) System, a left...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa